To test that hypothesis, we have previously used prostate cancer cells lines to demonstrate that blocking PACE4 expression levels results in significant anti-proliferative effects and reduced tumor size in xenograft animal models [17]. The gene discussed is PCSK6; the disease is prostate carcinoma.